|
|
||||||||
ORIGINAL RESEARCH |
From the Department of Obstetrics and Gynecology, Memorial University of Newfoundland, St. Johns, Newfoundland, Canada; Department of Obstetrics and Gynecology; and Department of Community Health and Epidemiology, Dalhousie University, Halifax, Nova Scotia, Canada; and Department of Obstetrics and Gynecology, Yale University School of Medicine, New Haven, Connecticut.
Address reprint requests to: Joan Crane, MD, Grace General Hospital, St. Johns, Newfoundland A1E 1P9, Canada
Objective: To determine the value of markers for predicting spontaneous preterm birth.
Methods: One hundred forty asymptomatic gravidas were recruited from 2024 weeks gestation. Risk score was assessed, vaginal swabs were analyzed for bacterial vaginosis, and cervical and vaginal swab were tested for fetal fibronectin FDC-6, X18A4, and CAF. Univariate analysis was used to determine potential predictors (and combinations of predictors) of outcome. Multiple logistic regression was done to identify independent predictors of spontaneous preterm birth. Sensitivity, specificity, positive and negative predictive values; and odds and likelihood ratios were calculated for significant predictors.
Results: Predictors significantly associated with the primary outcome were preterm birth-risk score and vaginal fetal fibronection FDC-6 (logistic regression odds ratio [OR] 16.9 [95% confidence interval (CI) 3.1, 92.8]) and 8.0 ([95% CI 1.6, 38.2], respectively). Bacterial vaginosis, fetal fibronectin X18A4, fibronectin CAF, and cervical fetal fibronectin FDC-6 were not associated with spontaneous preterm birth; however, the statistical power to assess these variables was limited. The combination of positive preterm birth-risk score and vaginal fetal fibronectin FDC-6 had a sensitivity of 44.4%, specificity of 97.7%, positive predictive value of 57.1%, negative predictive value of 96.2%, and a significant likelihood ratio for a positive test of 19.4 (95% CI 5.1, 73.8).
Conclusion: The combination of preterm birth-risk score and vaginal fetal fibronectin FDC-6 predicted spontaneous preterm birth. Intervention trials are required to determine whether a combination of screening tests will reduce rates of spontaneous preterm birth.
This article has been cited by other articles:
![]() |
S. Bergstrom Infection-Related Morbidities in the Mother, Fetus and Neonate J. Nutr., May 1, 2003; 133(5): 1656S - 1660. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Honest, L. M Bachmann, J. K Gupta, J. Kleijnen, and K. S Khan Accuracy of cervicovaginal fetal fibronectin test in predicting risk of spontaneous preterm birth: systematic review BMJ, August 10, 2002; 325(7359): 301 - 301. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. C. LU, R. L. GOLDENBERG, S. P. CLIVER, U. S. KREADEN, and W. W. ANDREWS Vaginal Fetal Fibronectin Levels and Spontaneous Preterm Birth in Symptomatic Women Obstet. Gynecol., February 1, 2001; 97(2): 225 - 228. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |